HOME ȸ»ç¼Ò°³ ½ÃÀÛÆäÀÌÁö·Î Áñ°Üã±âÃß°¡ ±âÀÚȸ¿ø½Åû
[¸ð¹ÙÀϸðµå] ·Î±×ÀΠȸ¿ø°¡ÀÔ
2024³â03¿ù29ÀÏfri
±â»çÃÖÁ¾ÆíÁýÀÏ: 2024-03-29 08:00:38
´º½ºÈ¨ > Á¦¾à > Á¦Á¶/¼öÀÔ/¼öÃâ
2017³â10¿ù11ÀÏ 11½Ã53ºÐ
±ÛÀÚÅ©±â ±â»ç³»¿ë À̸ÞÀϺ¸³»±â ´º½ºÇÁ¸°Æ®Çϱ⠴º½º½ºÅ©·¦Çϱâ
´ë¿õ '°ñ´Ù°øÁõÄ¡·áÁ¦ Á¹·¹µå·Ð»ê ÁÖ Çã°¡, ÆDZÇ' Àμö
2014³âºÎÅÍ ±¹³» µ¶Á¡ ÆǸš¥'BP °è¿­ ÁÖ»çÁ¦' °¡Àå ¸¹Àº ÀûÀÀÁõ º¸À¯

[º¸°ÇŸÀÓÁî] ´ë¿õÁ¦¾àÀÌ ³ë¹ÙƼ½º¿Í Çѱ¹»êµµ½º·ÎºÎÅÍ °ñ´Ù°øÁõ Ä¡·áÁ¦ 'Á¹·¹µå·Ð»ê ÁÖ 5§·/100ml(»çÁø)'ÀÇ ±¹³» ÆDZǰú Çã°¡±ÇÀ» ÀμöÇß´Ù.

´ë¿õÁ¦¾àÀº Çѱ¹»êµµ½º¿Í À¯Åë/ÆǸŠ°è¾à(Distribution and Promotion Agreement)¿¡ µû¶ó 2014³âºÎÅÍ '»êµµ½ºÁ¹·¹µå·Ð»ê ÁÖ 5§·/100ml'¸¦ ±¹³» µ¶Á¡ ÆǸÅÇØ¿Ô´Ù.

´ë¿õÁ¦¾à(´ëÇ¥ ÀÌÁ¾¿í)¿¡ µû¸£¸é '»êµµ½ºÁ¹·¹µå·Ð»ê ÁÖ'´Â ´ëÇ¥Àû °ñ´Ù°øÁõ Ä¡·á Á¦Á¦ÀÎ ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ®(ÀÌÇÏ BP) °è¿­ÀÇ ÁÖ»çÁ¦·Î 1³â¿¡ 1ȸ Åõ¾àÇÑ´Ù.

ÀÌ ¾àÀº Æó°æ ÈÄ ¿©¼ºÀÇ °ñ´Ù°øÁõ Ä¡·á¿Í ¿¹¹æ, ³²¼ºÀÇ °ñ´Ù°øÁõ Ä¡·á, ÀúÃæ°Ý °í°üÀý °ñÀý ÈÄ »õ·Î¿î °ñÀý¿¹¹æ µî BP Á¦Á¦ Áß °¡Àå ¸¹Àº ÀûÀÀÁõÀ» °¡Áö°í ÀÖ´Ù.

´ë¿õÁ¦¾à °ü°èÀÚ´Â "À̹ø ÆDZÇÀμö Á¶Ä¡·Î Á¦Ç°¶óÀξ÷ °­È­¿Í ÇÔ²² ¾ÈÁ¤ÀûÀÎ ¸ÅÃâ ¼öÀÍ¿øÀ» Ãß°¡ÇÒ ¼ö ÀÖ°Ô µÆ´Ù"¸ç "ÇâÈÄ ¿¬¸ÅÃâ 200¾ï ¿ø ´ëÀÇ Á¦Ç°À¸·Î ¼ºÀå½ÃÄÑ ³ª°¥ °Í"À̶ó°í ¸»Çß´Ù. 

BP °è¿­ÀÇ Àüü ½ÃÀå ±Ô¸ð´Â 2016³âÀ» ±âÁØÀ¸·Î Àâ¾Æ ¾à 1200¾ï ¿ø ¼öÁØÀ̸ç Áö³­ÇØ '»êµµ½ºÁ¹·¹µå·Ð»ê ÁÖ'ÀÇ ¸ÅÃâÀº 81¾ï ¿ø(IMS ±âÁØ)À̾ú´Ù.


DW acquires marketing authorization and commercial rights for an osteoporosis drug for Korea  
 
Daewoong Pharmaceuticals (CEO Jong-wook Lee) announced that it has acquired from Novartis and Sandoz Korea the marketing authorization and commercial rights to Sandoz product 'Zoledronic Acid Injection 5§·/100ml'.

Daewoong Pharmaceuticals has been selling Sandoz Zoledronic Acid Injection 5§·/100ml' in Korea exclusively since 2014 under a distribution and promotion agreement with Sandoz Korea. 

Sandoz Zoledronic Acid is a bisphosphonate injection, which is one of the most widely prescribed treatments for osteoporosis and it administered once a year. Zoledronic acid has the most number of indications among the bisphosphonates, and they are treatment and prevention of osteoporosis in post-menopausal women, the treatment of osteoporosis men, prevention of bone fracture after a low-trauma hip fracture, etc.
 
A Daewoong official said "with the acquisition of the rights to the drug, Daewoong will not only be able to strengthen its product line-up but also to secure a steady cash-flow", and he also said that, "Daewoong will try to increase its sales to reach 20 billion KRW in the future".
 
Bisphosphonate class, which is one of osteoporosis treatments, market size was about 120 billion KRW in 2016 and the sales of 'Sandoz Zoledronic Acid' was about 8.1 billion KRW last year).

°ü·Ã±â»ç°¡ ¾ø½À´Ï´Ù
´º½º½ºÅ©·¦Çϱâ
Á¶ÇöÁø (bktimes@naver.com) ±âÀÚ 
À̱âÀÚÀÇ ´Ù¸¥´º½ºº¸±â
Á¦Á¶/¼öÀÔ/¼öÃâ¼½¼Ç ¸ñ·ÏÀ¸·Î
¾È±¹¾àÇ°, C-GMP °øÀå Âø°ø
ÀǾàÇ° »ê¾÷À» ³»¼öÁöÇâÇü...
À¯À¯Á¦¾à, »ó¹Ý±â ´ÜÇÕ´ëȸ...
º£¸£³ª¹ÙÀÌ¿ÀÅØÄÚ¸®¾Æ, ±Û...
´ë¿õÁ¦¾à, K-Á¦¾à¡¤¹ÙÀÌ¿À ...
´ÙÀ½±â»ç : ³ì½ÊÀÚ, ¿Ã 3ºÐ±â ¿µ¾÷ÀÍ 420¾ï 'Àü³âÝï 21.3%¡è' (2017-10-31 11:26:37)
ÀÌÀü±â»ç : ½ÅdzÁ¦¾à, '±â¾÷°ú SP-8203 »õ ÀÛ¿ë±âÀü °ø°³' Áõ±Ç°è ÁÖ¸ñ (2017-09-27 17:34:52)
º´¿ø°è, "°è...
º´¿ø°è, "°è¹¦³â...
Á¦¾à¡¤°Ç½Ä 12°³...
°Çº¸°ø´Ü, ¼Ò¼Ó±â°ü '¼­¿ï¿ä¾ç...
¼ºÀåÇÏ°íÇ ´ç½Å, "Áö±Ý ´ë¿õ,...
º¸·ÉÁ¦¾à, ¿Ã »ó¹Ý±â '¿µ¾÷Á÷ ...
°Çº¸°ø´Ü, ¿ÃÇØ '°³¹æÇü Á÷°ú ...
°Çº¸°ø´Ü, '¿Ã Á¦3Â÷ °³¹æÇü ...
³í¹®) Inhalation Delivery of Interferon-¥ë-Loaded....  
ȸ»ç¼Ò°³ °³ÀÎÁ¤º¸º¸È£Á¤Ã¥ ÀÌ¿ë¾à°ü À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ ¾Ë¸³´Ï´Ù º¸µµÀÚ·á ±â»çÁ¦º¸ Á¤±â±¸µ¶